Low ImpactRegulation

Symbiotec Pharmalab shares update under SEBI insider trading norms

SYMBIOTEC 03092026133336 Reg 8 2 Code of practice UPSISource: NSE Filing3 Sept 2026

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

Symbiotec Pharmalab filed an update under SEBI's insider trading regulations. The disclosure follows Regulation 8(2) of the Prohibition of Insider Trading norms. No material financial or operational details were revealed. This is a routine compliance filing.

📊 STOCKS: $SYMBIOTEC | 🏢 SECTOR: Pharma | #LOWIMPACT #SEBI

#SEBI#InsiderTrading#RegulatoryFiling

SYMBIOTEC

This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.